Go to content

European Society for ME - Research & Knowledge

  • ESME
  • Contact
  • Search
  • Translation
  • Home
  • XMRV/MLV Seminar Oslo
  • Danish Conference
  • Recent UPDATES
  • ESME
  • News
  • ME - Facts and Figures
  • Treatment
    • Antivirals
    • Parasites/ Anti-parasites
    • Antibiotics
    • Diet
    • Supplements
    • CBT
    • Pacing
    • Lifestyle
  • Testing
  • Kids
  • Resources/Guidelines
  • Public Conferences
  • Media
  • Donate
  • Comments
  • XMRV
  • ME Organisations
  • FORUM

You are here:

  • Home
  • Treatment
  • Antibiotics
  • Lyme Disease – Its Cause, Symptoms and Treatments: An Interview with Professor Garth Nicolson

    Professor Garth Nicolson, PhD, director of the Institute for Molecular Medicine in Huntington Beach, CA, was a featured speaker at the International Lyme and Associated Diseases Society Annual Conference in Jersey City, NJ on Oct. 14-17, 2010. This interview highlights key points in Dr. Nicolson's presentation to the ILADS group - “Reversing Mitochondrial Damage and Increasing Cellular Energy in Chronic Lyme and Lyme-Associated Infections.”

    • Read more
  • Antibiotics recommended when indicated for treatment of Gulf War Illness/Chronic Fatique Syndrome, Fibromyalgia Syndrome, Rheumatoid Arthritis and other Autoimmune illnesses

    By Prof. Garth L. Nicolson

    • Read more
  • Azithromycin in Chronic Fatigue Syndrome (CFS), an analysis of clinical data

    In a retrospective study from Ruud Vermeulen, the response of CFS patients to azithromycin, an antibiotic and immunomodulating drug, has been scored from the patients records and compared with clinical and laboratory data. Azithromycin was not the first choice therapy, but offered when the effect of counseling and L-carnitine was considered insufficient by the patient and the clinician. Lower plasma acetylcarnitine was observed in CFS patients who responded to azithromycin. The lower plasma acetylcarnitine level may indicate a decreased ability to counteract the action of the increased oxidative stress and/or an increased consumption of acetylcarnitine by the increased oxidative stress.

    • Read more

News

  • 15.06.2009 Think Tank mentioned on Sky News
  • 08.06.2009 Conference on ME/CFS in Stavanger is open for patients and relatives
  • 27.01.2012 Persbericht: Petitie ME-patiënten: Erken ME als invaliderende biomedische ziekte
  • 24.01.2012 Response to ‘A controversial consensus’; By the International Consensus Panel, Journal of Internal Medicine
  • 24.01.2012 A controversial consensus – comment on article by Broderick et al, Journal of Internal Medicine
  • News archive

ESME.com is designed, developed and hosted by Norsk Kunde & Medlemsutvikling